article thumbnail

ECG Cases 45 ECG in Weakness and Neurological Symptoms

ECG Cases

The post ECG Cases 45 ECG in Weakness and Neurological Symptoms appeared first on Emergency Medicine Cases.

article thumbnail

Eagle’s Eye View: The New AHA/ACC Hypertrophic Cardiomyopathy Guideline, Smoking Cessation, Embolic Stroke

American College of Cardiology

In this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after initial treatment failure with varenicline or nicotine.

article thumbnail

Torsade in a patient with left bundle branch block: is there a long QT? (And: Left Bundle Pacing).

Dr. Smith's ECG Blog

(And of course Ken's comments at the bottom) An elderly obese woman with cardiomyopathy, Left bundle branch block, and chronic hypercapnea presented hypoxic with altered mental status. CT of the chest showed no pulmonary embolism but bibasilar infiltrates. She was intubated. T-waves are quite tall and possibly peaked (HyperK?),

article thumbnail

PO-04-089 ATRIAL MECHANICAL REMODELING COULD BE PREDICTABLE FOR NEWLY DEVELOPED ATRIAL FIBRILLATION IN PATIENTS WITH EMBOLIC STROKE WITH UNDETERMINED SOURCE

HeartRhythm

Atrial fibrillation (AF) has been known as a main cause of embolic stroke. Well-chosen candidate to be anticoagulated should be critical for secondary prevention in patients with embolic stroke with undetermined source (ESUS).

article thumbnail

PO-04-094 IMPROVED PREDICTION MODEL FOR RISK OF ATRIAL FIBRILLATION IN HYPERTROPHIC CARDIOMYOPATHY : LEAP-HCM SCORE

HeartRhythm

Atrial fibrillation(AF) is associated with increased risk of embolic stroke and heart failure hospitalizations in patients with hypertrophic cardiomyopathy(HCM).

article thumbnail

Abstract WMP98: Use of Direct Oral Anticoagulants (DOACs) Compared to Aspirin for Secondary Prevention of Embolic Stroke of Undetermined Source (ESUS): A Systematic Review and Meta-analysis.

Stroke Journal

Background:The use of oral anticoagulation (OAC) for stroke prevention in embolic stroke of undetermined source (ESUS) is hypothesized to be beneficial over conventional antiplatelet use. Among the atrial cardiomyopathy subgroup, no benefit was observed (OR 0.88; 95% CI 0.50 - 1.55; p = 0.67; I2 = 39%).Conclusion:There

article thumbnail

Hypertrophic Cardiomyopathy

All About Cardiovascular System and Disorders

Hypertrophic cardiomyopathy is a genetic disorder with a guarded prognosis which occurs in about 1:500 individuals. The most common symptom of hypertrophic cardiomyopathy is dyspnoea which occurs in 90% of cases and is due to elevated left ventricular diastolic pressures as a consequence of the diastolic dysfunction.